Home › Orexigen Therapeutics resubmits Contrave to FDA
 

Keywords :   


Orexigen Therapeutics resubmits Contrave to FDA

2013-12-12 11:39:48| Biotech - Topix.net

The FDA refused to approve Contrave in 2011, citing concerns over cardiovascular risk.

Tags: fda therapeutics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »